Anna Jirkovská Selected Research

ICRF 198

1/2018

Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Jirkovská Research Topics

Disease

7	Cardiotoxicity 11/2021 - 09/2016
2	Heart Failure 11/2021 - 01/2020
2	Adenocarcinoma 01/2015 - 01/2014
2	Neoplasms (Cancer) 01/2015 - 01/2014
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Leukemia 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Iron Overload 09/2014

Drug/Important Bio-Agent (IBA)

7	IronIBA 11/2021 - 01/2014
6	AnthracyclinesIBA 11/2021 - 01/2018
5	Dexrazoxane (Zinecard)FDA LinkGeneric 11/2021 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
3	ProdrugsIBA 01/2021 - 01/2018
2	MetalsIBA 11/2021 - 01/2020
2	4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA 01/2021 - 01/2021
2	Chelating AgentsIBA 01/2015 - 09/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2021
1	PropaneIBA 01/2020
1	ICRF 198IBA 01/2018
1	CatecholaminesIBA 09/2016
1	SemicarbazonesIBA 01/2015
1	LigandsIBA 01/2014
1	HydrazonesIBA 01/2014
1	BromineIBA 01/2014